-Mei Lu Researcher Activity Profile

Research Author Detailed Information 

Mei Lu Publication Rate By Year

Mei Lu has published 1 paper(s) in 2004, 2 paper(s) in 2006, 15 paper(s) in 2007, 7 paper(s) in 2008, for a total of 25 research publications in total.

Mei M Lu Author Information

LAST NAME: lu

FIRST NAME: mei

INITIALS: M

AFFILIATION:

Papers

Mei Lu's Publication Record

1. Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer. Year Published: 2007
Department of Radiation Oncology, Henry Ford Health System, Detroit, Michigan 48202, USA. sfreyta1@hfhs.org
2. Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity. Year Published: 2006
Department of Radiation Oncology, Henry Ford Health System, Detroit, MI 48202, USA.
3. [The original meaning of concept of Shichen in acupoint selection according to time] Year Published: 2006
Henan College of TCM, Zhengzhou 450008, China.
4. Five-year Follow-up of Trial of Replication-competent Adenovirus-mediated Suicide Gene Therapy for Treatment of Prostate Cancer. Year Published: 2007
1Department of Radiation Oncology, Henry Ford Health System, Detroit, Michigan, USA.
5. Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Year Published: 2007
Henry Ford Hospital, Department of Otolaryngology/Head and Neck Surgery, Detroit, Michigan 55905, USA. mworsha1@hfhs.org
6. Second hip fracture in older men and women: the Framingham Study. Year Published: 2007
Department of medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA. sarahberry@hrca.harvard.edu
7. Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth. Year Published: 2007
Departments of Neurology, Henry Ford Health Sciences Center, Detroit, Michigan, USA.
8. A model for optimizing adenoviral delivery in human cancer gene therapy trials. Year Published: 2007
Department of Radiation Oncology, Henry Ford Health System, Detroit, MI 48202, USA.
9. Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer. Year Published: 2007
Department of Radiation Oncology, Henry Ford Health System, Detroit, Michigan 48202, USA. sfreyta1@hfhs.org
10. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Year Published: 2007
Department of Otolaryngology/Head and Neck Surgery, Henry Ford Health System, Detroit, Michigan 48202, USA. mworsha1@hfhs.org
11. Second hip fracture in older men and women: the Framingham Study. Year Published: 2007
Department of medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA. sarahberry@hrca.harvard.edu
12. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Year Published: 2007
Department of Otolaryngology/Head and Neck Surgery, Henry Ford Health System, Detroit, Michigan 48202, USA. mworsha1@hfhs.org
13. The linkage of neural progenitor cell cycle profiles between embryonic and adult stroke models: Analytical approach II. Year Published: 2007
Department of Biostatistics and Research Epidemiology, Henry Ford Hospital, One Ford Place, Ste. 3E, Detroit, MI 48202, USA; Department of Neurology, Henry Ford Hospital, Detroit, MI 48202, USA.
14. Atorvastatin promotes presenilin-1 expression and Notch1 activity and increases neural progenitor cell proliferation after stroke. Year Published: 2007
Department of Neurology, Henry Ford Health Sciences Center, Detroit, MI 48202, USA. Jieli@neuro.hfh.edu
15. Atorvastatin promotes presenilin-1 expression and notch1 activity and increases neural progenitor cell proliferation after stroke. Year Published: 2007
Neurology Research, E&R Bldg, Room 3056, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202. Jieli@neuro.hfh.edu.
16. Determination of zonal boundaries in articular cartilage using infrared dichroism. Year Published: 2008
Department of Physics and Center for Biomedical Research, Oakland University, Rochester, Michigan 48309.
17. Determination of zonal boundaries in articular cartilage using infrared dichroism. Year Published: 2008
Department of Physics and Center for Biomedical Research, Oakland University, Rochester, Michigan 48309.
18. Atorvastatin promotes presenilin-1 expression and Notch1 activity and increases neural progenitor cell proliferation after stroke. Year Published: 2007
Department of Neurology, Henry Ford Health Sciences Center, Detroit, MI 48202, USA. Jieli@neuro.hfh.edu
19. Determination of zonal boundaries in articular cartilage using infrared dichroism. Year Published: 2008
Department of Physics and Center for Biomedical Research, Oakland University, Rochester, Michigan 48309, USA.
20. Determination of zonal boundaries in articular cartilage using infrared dichroism. Year Published: 2008
Department of Physics and Center for Biomedical Research, Oakland University, Rochester, Michigan 48309, USA.
21. [Multi-central clinical valuation of ginger-partitioned moxibustion for treatment of luekopenia induced by chemotherapy] Year Published: 2008
The Third Affiliated Hospital, College of TCM of Henan, Zhengzhou 450008, China. zhaoxixin10@yahoo.com.cn
22. Multiparametric iterative self-organizing MR imaging data analysis technique for assessment of tissue viability in acute cerebral ischemia. Year Published: 2004
Department of Neurology, Henry Ford Health Sciences Center, Detroit, MI, USA.
23. Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. Year Published: 2008
1Department of Neurology, Henry Ford Health System, Detroit, Michigan, USA.
24. Lengthening the G(1) phase of neural progenitor cells is concurrent with an increase of symmetric neuron generating division after stroke. Year Published: 2008
Department of Neurology, Henry Ford Health System, Detroit, MI 48202, USA.
25. Five-year follow-up of trial of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancer. Year Published: 2007
Department of Radiation Oncology, Henry Ford Health System, Detroit, Michigan, USA.